InvestorsObserver
×
News Home

Should Abbott Laboratories (ABT) Stock be in Your Portfolio?

Monday, October 19, 2020 01:16 PM | InvestorsObserver Analysts

Mentioned in this article

Should Abbott Laboratories (ABT) Stock be in Your Portfolio?

Abbott Laboratories (ABT) stock is up 34.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ABT stock a score of 68 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 83. ABT's rank also includes a short-term technical score of 73. The fundamental score for ABT is 47. In addition to the average rating from Wall Street analysts, ABT stock has a mean target price of 112.833. This means analysts expect the stock to rise 2.93% over the next 12 months.

Overall Score - 68
ABT has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ABT!

What's Happening with ABT Stock Today

Abbott Laboratories (ABT) stock has fallen -0.05% while the S&P 500 is lower by -0.43% as of 1:09 PM on Monday, Oct 19. ABT is lower by -$0.05 from the previous closing price of $109.67 on volume of 2,083,958 shares. Over the past year the S&P 500 is higher by 15.37% while ABT is up 34.26%. ABT earned $1.74 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 62.84.

Click Here to get the full Stock Score Report on Abbott Laboratories (ABT) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App